IVCA - Third quarter venture capital funding falls to lowest level in ten years

IVCA - Third quarter venture capital funding falls to lowest level in ten years

Richard Watson and Sarah-Jane Larkin

Venture capital funding into Irish technology SMEs suffered its worst third quarter in ten years, according to the Irish Venture Capital & Private Equity Association (IVCA) VenturePulse survey, published on Sunday in association with William Fry. Funding for the quarter fell by 45 per cent to €113.8m from €207.9m in the same period last year.

Funding for the nine months to end September fell 19 per cent to €692.2m, from €853.4m in 2025.

Richard Watson, chairperson, IVCA, said that the poor quarter was partially due to a retreat by global investors. “Funding by international VCs plummeted 76 per cent to just €35.5m from €146.7m in the same quarter last year. We have been warning for some time about our overdependence on international investors.”

He said that another worrying feature of the third quarter was the squeeze on Irish firms looking to raise between €1m-€5m. “The number of deals in this category declined by over a half to 12 from 30 last year. Deals in the €1m-€3m declined by 70 per cent to €10.7m while €3m-€5m rounds fell 55 per cent to €15.7m.”

Mr Watson said that many Irish VC firms are working towards launching new funds backed by the Government’s Enterprise Ireland Seed & Venture Capital Scheme. “But despite many exciting investment opportunities in the local market, VCs are finding it difficult to get over the line with sufficient matching funding from private sources such as institutional investors, including pension funds.

“Enterprise Ireland’s continued support, including through the Seed and Venture Capital Scheme, is welcome in a challenging market. Its role sits alongside the need to attract more private capital and broaden the funding options available to Irish businesses.”

He added that while there was not a big fall off in the number of deals for the first nine months (129 compared to 136 last year), the mix in the third quarter had changed substantially, with more very small rounds, fewer €1m-€5m and no €30m-plus deals. “The issue is less about the overall level of activity and more about whether companies can progress through the funding ladder from pre-seed to seed and into larger scale-up rounds.”

Sarah-Jane Larkin, director general, IVCA, said the that strain on Irish tech SMEs looking to raise €1m-€5m was reflected in the nine months to date. “Funding in the €3m-€5m range fell by over a half (56 per cebt) during the nine months to €37.2m. Deals from €1m-€3m were down by over a third (36 per cent) to €48.7m. The number of rounds across both categories fell from 65 to 40 this year.”

Commenting on recent turbulence in Stock Market valuations of AI companies following US midterm elections, Mr Watson said that Ireland was somewhat shielded as it did not possess big, domestic frontier, platform companies investing billions in AI infrastructure such as data centres.

“AI is here to stay, and Ireland has many companies applying it to solve real industry problems in areas such as healthcare, financial services, manufacturing and construction. These businesses will require normal levels of venture-scale funding rather than the extraordinary sums being invested by global model developers.”

Life sciences companies led the way in funding in the first nine months of the year accounting for €163.2m or 24 per cent of the total. This was followed by fintech with €154.2m or 22 per cent of the total. Software accounted for €110.6m (16 per cent) and cybersecurity €91.4m (13 per cent).

Join over 12,500 lawyers, north and south, in receiving our FREE daily email newsletter
Share icon
Share this article: